Skip to main content

Best Practices

“There is a very strong link between shift work and lack of sleep, and fewer hours of sleep can translate to a higher risk for obesity and disease,” according to Eva S. Schernhammer, MD, DrPH, who spoke at the recent American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research. Read More ›

Biosimilar Effective for Chemotherapy-Induced Anemia in Patients with Colorectal Cancer
Data presented at the 2015 Gastrointestinal Cancers Symposium illustrated that the biosimilar epoetin alfa (HX575, Binocrit) can safely correct anemia and maintain hemoglobin levels. Read More ›

Because of the complexity of biosimilar regulations, a pharmaceutical and therapeutics committee—which includes pharmacists and physicians—is recommended to determine appropriate biosimilar use... Read More ›

The expanding availability of oral drugs for the treatment of a number of tumor types has increased their use as chemotherapy. Read More ›

The Jefferson School of Pharmacy at Thomas Jefferson University was founded in 2008 and offers an innovative doctor of pharmacy program that prepares graduates for interesting and challenging pharmacy practice roles across the healthcare continuum. Read More ›

With little information in the literature, pharmacists and oncologists may feel insecure about the use of chemotherapy in a pregnant patient. Read More ›

Systematic application of oncology clinical pathways can reduce variation in cancer disease management and result in significant overall savings, said Jim Koeller, MS, at the Hematology/Oncology Pharmacy Association 9th Annual Conference Read More ›

Pharmacists can play a role in overcoming patients’ financial and personal obstacles to oral chemotherapy. Read More ›

Pharmacists can serve as an important information portal for access to investigational drugs through clinical trials or via expanded-access mechanisms. Read More ›

Meta-Analysis Actually Shows Fewer Serious Adverse Events
Ameta-analysis reported at the 2012 Annual Meeting of the Ameri­can Society of Clinical Oncology (ASCO) supports the new guidelines that recommend weight-based chemotherapy dosing for obese cancer patients.1,2 Read More ›

Page 2 of 3